BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 170826)

  • 1. Evaluation of serum progesterone during treatment of malignant trophoblastic disease.
    Dawood MY
    Am J Obstet Gynecol; 1975 Oct; 123(3):291-8. PubMed ID: 170826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum progesterone and serum human chorionic gonadotropin in gestational and nongestational choriocarcinoma.
    Dawood MY
    Am J Obstet Gynecol; 1975 Dec; 123(7):762-5. PubMed ID: 1200070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum progesterone and serum chorionic gonadotrophin in hydatidiform mole and choriocarcinoma.
    Teoh ES; Das NP; Dawood MY; Ratnam SS
    Acta Endocrinol (Copenh); 1972 Aug; 70(4):791-800. PubMed ID: 5068403
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
    Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluctuations of plasma progesterone, 17alpha-OH-progesterone and estrogens in trophoblastic diseases (author's transl)].
    Miyamoto T
    Nihon Naibunpi Gakkai Zasshi; 1977 Mar; 53(3):203-20. PubMed ID: 199477
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
    Goldstein DP
    Am J Obstet Gynecol; 1971 Jun; 110(4):583-7. PubMed ID: 4325820
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of serum progesterone and serum unconjugated oestradiol-17beta in unaborted hydatidiform mole.
    Dawood MY
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):729-39. PubMed ID: 169657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
    Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical evaluation of the simultaneous measurements of human chorionic gonadotropin (hCG) and its alpha-subunit in sera of patients with trophoblastic diseases.
    Nishimura R; Ashitaka Y; Tojo S
    Endocrinol Jpn; 1979 Oct; 26(5):575-83. PubMed ID: 527560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB; Lehr M; Lewis JL
    Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
    [No Abstract]   [Full Text] [Related]  

  • 16. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM; Seppälä M
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
    Seki K; Uesato T; Kato K
    Endocrinol Jpn; 1986 Oct; 33(5):727-33. PubMed ID: 3030714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human chorionic gonadotropin molecule from patients with trophoblastic diseases has a high thyrotropic activity but is less active in the ovary.
    Kato K; Mostafa MH; Mann K; Schindler AE; Hoermann R
    Gynecol Endocrinol; 2004 May; 18(5):269-77. PubMed ID: 15346663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P; Leyendecker G
    Arch Gynecol; 1979 Jul; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.